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Abstract Increased generation of active oxygen species uch as cluding c-myc and c-fos [6]. Other investigators have also 
hydrogen peroxide (H202) may be important in vascular smooth demonstrated that H202 and 02- stimulate growth-related 
muscle cell growth associated with atherosclerosis and restenosis, events such as cell alkalinization and proto-oncogene induc- 
In this work, we showed that H202 was a potent mitogen for tion [17,18] and it has been recently demonstrated that H~O2 
growth-arrested cultured human aortic smooth muscle cells was required as a signal transducing molecule for platelet 
(SMC), stimulating an increase in cell number at 10 nM to derived growth factor (PDGF) to stimulate the growth of 
100 p,M concentration. This effect was inhibited in a dose- vascular SMCs [19]. In addition, evidence indicates that ex- 
dependent manner by catalase, deferoxamine, dimethylthiourea perimental atherosclerosis, restenosis and foam cell formation 
or probucol showing that it was dependent on the oxidative can be effectively retarded by antioxidants [20--24] and the 
activity ofH202. H202-induced SMC proliferation was strongly administration of antioxidants to human subjects has been 
and specifically inhibited by a neutralizing monoclonal antibody shown to increase the resistance of their low density lipopro- 
directed against basic fibroblast growth factor (bFGF) but was 
teins to oxidation and to protect against atherosclerosis [25 not due to increased expression of bFGF or the bFGF receptor-1 
(FGFR-1) by SMC. H202 strongly increased the affinity of 28]. 
bFGF for its receptor-1 at the surface of the SMC, therefore In view of these data, the present study was undertaken to 
showing that the mitogenic effect of H202 might occur through a gain an insight into the mechanism by which the oxidant 
direct effect on the bFGF receptor. H.202 stimulates the growth of human aortic SMCs in culture 
and to test the possible involvement of growth factors in this 
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2. Materials and methods 
1. Introduction 2.1. Materia& 
H20~, catalase, probucol and dimethylthiourea (DMTU) were ob- 
The accumulation of neointimal smooth muscle cells (SMC) tained from Sigma Chemical Co. (L'Isle d'Abeau, France). Deferox- 
resulting from media smooth muscle proliferation and migra- amine (DFO) was obtained from Ciba (Summit, N J, USA). All cul- 
ture reagents were purchased from Boehringer Mannheim 
tion in response to vascular injury is believed to be one of the (Mannheim, Germany). Monoclonal neutralizing antibodies against 
main events involved in the initiation of atherosclerosis [1,2]. human bFGF (Ab-bFGF), PDGF-BB (Ab-PDGF), aFGF (Ab- 
Nevertheless, the mechanism by which various types of aFGF), TGF[3 (Ab-TGF) and EGF (Ab-EGF) were obtained from 
growth factors are secreted by platelets, macrophages or vas- R&D Systems (Minneapolis, MN). 
cular cells to initiate and sustain the replication of vascular 2.2. Culture and proliferation assays qfhuman vascular smooth muscle 
SMC leading to the formation of neointima after vascular cells 
injury is poorly understood. Human aortic smooth muscle cells (ASMC) were purchased from 
Although the general contribution of growth factors and Clonetics (Le Perray, France). These cells were routinely cultured in 
Dulbecco's modified Eagle medium (DMEM) supplemented with 10% 
cytokines in the development of atherosclerosis has been ac- fetal calf serum (FCS), 50 U/ml of penicillin, 50 ~tg/ml of streptomycin 
knowledged for a long time, recent investigations suggest hat sulfate and 4 mM glutamine (Boehringer-Mannheim, France). For 
oxidants, since they have been shown to activate a number of measurement of cell growth, ASMC were seeded in DMEM+0.5% 
pathways that are also stimulated by growth factors, can be FCS at 1× l0 ~ cells per well (24-well plates, Falcon Beckton Dick- 
considered as early growth signals [3]. In particular, oxidants inson, Le Pont de Claix, France) for 3 days in a humidified CO2 
incubator maintained at 37°C. Culture medium was lhen removed 
can induce transcription of enzymes, such as ornithine decar- and cells were seeded in DMEM+0.5% FCS with various concentra- 
boxylase [4], phosphatase CL-100 [5] and of proto-oncogenes tions of H202. The inhibition of proliferation induced by H202 (0.1 
[6-9]. It has also been suggested that oxidants enhance the mM) by various compounds was also studied under the same experi- 
activity of protein kinase C (PKC) [10-13], that of the tran- mental conditions. For growth rate determination, after 3 days in 
culture, triplicate plates were trypsinised and the cells counted with 
scriptional activator NF-~cB and AP-1 [14] and activate MAP a Coulter counter (Coultronics, France). 
kinase in SMCs [15]. For binding experiments, ASMC were seeded in 24-well cluster 
Recent reports have also shown that hydrogen peroxide plates (3x104 cells/well) in DMEM+10% FCS and grown to conflu- 
(HzO2) stimulates DNA synthesis in SMC [6,16] and induces ence (4-5 days after plating) (2-3 × 1() ~ cells/well). Cells were routinely 
the expression of several growth-related proto-oncogenes, in- used between the third and 10th passage. 
2.3. 12~'I-bFGF binding to ASMC 
*Corresponding author. Fax: (33) 61 16 22 01. Experiments studying the specific binding of t2'SI-bFGF (110 gCi/ 
E-mail: jean-marc.herbert@tlsl.elfsanofi.fr p.g) (NEN Research Products, Dupont, France) to human ASMC 
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were performed on cells cultured in 24-well cluster plates. Subconflu- 
ent cultures (2 3x 105 cells/well) were incubated at 4°C for 10 min 
and washed twice with ice-cold DMEM supplemented with 25 mM 100 
HEPES (pH 7.4), 0.3 mg/ml soybean trypsin inhibitor (STI), 0.5 mg/ 
ml bacitracin and 0.2% gelatin (Sigma Chemical Co., L'Isle d'Abeau, 
France). Incubations were carried out in a total 200 gl volume of 
HEPES 25 mM (pH 7.4) supplemented with 0.3 mg/ml STI, 0.5 mg/ 80 
ml bacitracin and 0.2% gelatin which contained ifferent concentra- 
tions of 12SI-bFGF. Triplicate xperiments were carried out at 7°C for 
the indicated periods of time. To determine the total binding of 125I- .~- 60 
bFGF, the cells were incubated for 5 min in 1 ml of 1 M NaOH and N 
the extract was counted in a gamma counter. Non-specific binding 
was considered as the value obtained for high affinity binding in the 
presence of a 100-fold excess on non-labeled bFGF (Amersham; Les 40 
Ulis, France). In all experiments, representative w lls were trysinised 
and cells were counted with a Coulter counter. 
2.4. Expression of bFGF and FGFR-1 mRNA 20 
Total cellular RNA was isolated from 5× 106 cells according to 
Chomczynski and Sacchi [29] and bFGF and FGFR-1 mRNA expres- 
sion was analyzed by Northern blotting. Samples were size-fraction- 
ated by electrophoresis on 1% agarose gels containing 7.5% formal- 0 
I ~ I I I 
dehyde. Capillary transfer to Nylon N + (Amersham, UK) was 
performed overnight in standard saline citrate (SSC). Hybridizations 0.1 l 10 100 1000 
were carried out at 42°C for 18 h in hybridization buffer (50% for- Gatalase (U/ml) 
mamide, 1 M NaCI, 10 × Denhardt's olution, 0.5% sodium dodecyl DFO, DMTU, Probueol (pM) 
sulfate (SDS) and 100/ag/ml salmon sperm DNA). DNA probes used 
for Northern blot hybridization analysis were plasmid pJJl-I [30] and Fig. 2. Effect of various compounds on the mitogenic activity of 
clone pCD115 [31] for bFGF and FGFR-1, respectively. Washes were H202. Human SMCs (104 cells/well) were cultured in 24-well cluster 
performed at room temperature in 2xSSC, 0.1% SDS and finally at plates in DMEM+0.5% FCS. After 3 days, H202 (0.1 mM) was 
60°C in 0.1 × SSC, 0.1% SDS. Filters were rehybridized with a probe added in the presence of increasing concentrations of catalase (e), 
for human GAPDH as a control for the amount of RNA in each lane deferoxamine (•) ,  dimethylthiourea (11) or probucol (•) .  After 3 
and washed under the same conditions as above. Autoradiograms days in culture, cells were detached from triplicate wells and 
were obtained by exposure of filters to Amersham MP films at counted. Results are expressed as percent inhibition of the cell pro- 
liferation measured in the vehicle-treated wells. 
-80°C using two intensifying screens. Relative intensities of hybridi- 
90 zation signals were obtained by densitometer scanning of autoradio- 
t ~ 1 grams (Vilbert L°urmat' France)" 
80 2.5. Expression of data 
10% FCS All data are means of at least triplicate xperiments. The apparent 
70 dissociation constant (Kd) and the maximal number of binding sites 
/ , (Bn~,x) were calculated by using Scatchard representation f the ex- 
50 / perimental data [32]. Data from saturation studies were analyzed 
using a non-linear egression program [33]. 
~-" 45 
O 
40 3. Results and discussion 
35 
3.1. Mitogenic effect of  H202 on human vascular SMC 
E= 30 Although vascular SMC hyperplasia is now considered as a 
~" key event in atherogenesis and restenosis, specific regulatory 
25 
o mechanisms for cell proliferation in the arterial wall are still 
20 poorly characterized. While in vitro studies with vascular 
SMCs have identified several agents that stimulate their pro- 
15 liferation in culture, growth factors responsible for vascular 
10 ~ 0.5% FCS injury-induced intimal SMC replication have only begun to be 
identified. Along with PDGF [34], bFGF  [35] and several 
5 other growth factors and cytokines that are now considered 
to be likely candidates to play an important role in the for- 0 [ r i i i i ~ J 
-10 -9 -8 -7 -6 -5 -4 -3 mation of neointima following endothelial damage, oxidants, 
since they have been shown to activate a number of pathways 
Concentration (Log M) that are also stimulated by growth factors, can be considered 
Fig. 1. Mitogenic effect of H202 for human aortic SMCs. Human early growth signals [3]. 
SMCs were plated sparsely (104 cells/well) in 24-well cluster plates The molecular mechanisms associated with cell injuries 
in DMEM + 0.5% FCS. After 3 days, growth-arrested cells were ex- caused by oxidants are not completely understood but several 
posed to increasing concentrations of H202 (e), 0.5% FCS (11) or 
10% FCS (•) .  After 3 days, cells were detached from triplicate works suggest hat H202 might increase arachidonic acid re- 
wells by trypsin treatment and counted in a coulter counter. Results lease by stimulating membrane-associated phospholipase A2 
are expressed as mean cell numbers + SD (n = 6). (PLA2) activity [36,37], increase the activity of protein kinases 
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gest that the mitogenic effect of H202 occurs predominantly 
50 via OH- ,  the formation of which has been shown to occur 
with iron as a catalyst [44]. Stimulation of arachidonic acid 
F .~_ release from pulmonary SMC by H202 has been shown to 
40 • occur via the same mechanism [37]. Moreover, these results 
~ .... might provide an explanation for the antiproliferative activity 
o 
,~ i ~ of probucol, a compound which has been shown to decrease v 
30 ' the myointimal proliferation of injured vessels in animals re- 
ceiving a cholesterol-rich diet [22,23]. 
: In order to determine if such a mitogenic effect of H202 for 
20 i SMCs could be due to the release of growth factors by the 
! cells, we evaluated the activity of neutralizing monoclonal 
' antibodies directed against PDGF-BB, bFGF,  aFGF,  TGF[3 
1 ~] ,i i !i i and EGF. Only the monoclonal antibody directed against 
10 = ~ bFGF inhibited H202-induced growth of SMC (Fig. 3). 
This inhibitory effect did not occur with regard to fetal calf 
serum-induced SMC growth (not shown) and was not a gen- 
0 - -  f ~ ~ ! , , eral phenomenon i volving other growth factors since we ob- 
-~ " " " " " served no significant inhibitory effect of the monoclonal anti- o (.9 (.9 C9 C9 C5 
f-~ LL LL I-- ILl g 0_ .a ~ bodies directed against the other growth factors with regard 
0 to the mitogenic effect of H20~. 
Fig. 3. Effect of vanous antibodies on the mitogenie activity of 
H202. SMCs (104 cells/well) were cultured in 24-well cluster plates 3.2, Effect o f  H202 on bFGF and FGFR-1 expression in human 
in DMEM +0.5% FCS. After 3 days, H202 (0.1 mM) was added in SMCs 
the presence of 0.5% FCS and the indicated antibodies (100 btg/ml). Since our results demonstrate tbr the first time that HgO.~- 
After 3 days in culture, cells were detached from triplicate wells and - - 
counted. Results are expressed as mean cell numbers +SD (n = 6). induced SMC growth might occur via bFGF as an essential 
intermediary, we determined whether H202 could affect the 
expression of bFGF mRNA in SMC but, upon stimulation 
and phosphatases in vascular SMCs [15], activate early re- with H._,O,, no significant rise in bFGF mRNA expression 
sponse genes [6 9] and induce DNA synthesis in growth-at- was observed within SMCs (Fig. 4). A similar result was ob- 
rested cells in vitro [6,13,15,16,19] or in vivo following arterial rained with regard to the expression of the FGF receptor type 
injury [24]. On the basis of these findings, we hypothesized 1 (FGFR-1), the only type of receptor present on SMC [45], 
that active oxygen species should activate SMC growth via a therefore showing that the mechanism of the mitogenic action 
particular growth factor as already shown for numerous other of H202 was not at the level of the bFGF or FGFR- I  mRNA 
substances such as thrombin [38], tissue plasminogen activator transcription. 
[39] or hypoxia [40]. 
In the present study, we demonstrate that, when added to 
growth-arrested human SMCs, H202 exhibited a dose-de- 
pendent mitogenic effect (Fig. l). This activity was significant 
from the dose of 10 nM and reached a maximum between 0.1 1 2 3 
and 1 mM. At these concentrations, H202 induced a 4.5-fold 
increase in cell number over a period of 3 days. This effect 
represented about 60'/, of the mitogenic effect of 10% FCS. A 
The concentration of H202 required to obtain a half-maximal , = 
response (ED:,I) was of 0.2 + 0.04 [aM (n = 6). As shown in 
Fig. 2, the mitogenic effect of H202 was closely related to 
its oxidative activity since catalase and probucol inhibited in 
a dose-dependent manner H202-induced proliferation with 
ICa0 values of 20_+4 U/ml and 1.2+0.2 gM (n=6). It is 
noteworthy that these concentrations corresponded closely 
to the inhibitory effect of catalase and probucol with regard 
to the oxidative activity of H202 as measured in the incuba- 
tion medium (IC~0 = 17 + 5 U/ml and 1.0 _+ 0.3 iaM n = 6). The 
specific iron chelator DFO has been shown to modify tissue ~ 
changes observed in oxidant injury [41,42] and DFO is widely L; 
used as a probe to study iron-dependent radical(s) production 
[41]. Our present study indicates that pretreatment with DFO Fig. 4. Effect of H202 on the expression of bFGF and FGFR-1 
markedly reduced H202-induced SMC growth (Fig. 2). mRNA in SMCs. Growth-arrested SMCs (10 ~ cells) were incubated 
DMTU,  a potent OH" scavenger [43] also strongly inhibited for 3 days with saline (lane 1), H202 (0.1 rnM) (lane 2) or 10% 
FCS (lane 3). Total mRNA was purified and Northern blot analysis the mitogenic effect of H202 therefore demonstrating the ira- 
was performed by using cDNA probes for bFGF (A) or FGFR-I 
portance of this radical, as already shown on these same cells (B) described under Section 2. GAPDH (C) was used to normalize 
for other effects of H20~ [37]. Collectively, these results sug- RNA loading. Results are representative of 3 experiments. 
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150 sult in modification of cysteine residues in bFGF inactivate 
the growth factor [50,51]. 
In summary, our present results suggest that: (i) H202 
125 caused stimulation of SMC proliferation predominantly via 
its oxidative activity and in particular via OH" and iron; (ii) 
100 H202-induced SMC occurs via bFGF as an essential inter- 
mediary, an increase of the affinity of bFGF for its type-1 
receptor being primarily responsible for the mitogenic activity 
" of H202 for HASMC. 75 
Moreover, although these results uggest that H202 may act 
as a potent factor in the development of atherosclerosis and 
5o offer a rational explanation for the mechanism of the cardio- 
protective effect of antioxidants, the exact mechanism by 
which H202 directly affects FGFR-1 will have to be deter- 
25 mined precisely. 
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